Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
Efficacy and safety of venanprubart, a BTLA agonist antibody, in patients with active systemic lupus erythematosus.
Journal: EULAR rheumatology open
Published: August 01, 2026
Safety, Tolerability, Pharmacokinetics, and Immunogenicity of a BTLA Agonist Antibody (Venanprubart) in Healthy Participants, Patients with Systemic Lupus Erythematosus, and Patients with Psoriasis: Results From Three Phase 1 Studies.
Journal: Clinical pharmacology in drug development
Published: August 08, 2025
Role of interferon regulatory factor 7 in serum-transfer arthritis: regulation of interferon-β production.
Journal: Arthritis and rheumatism
Published: November 15, 2011
Targeting interferon regulatory factors to inhibit activation of the type I IFN response: implications for treatment of autoimmune disorders.
Journal: Cellular immunology
Published: February 14, 2011
Synoviocyte innate immune responses: II. Pivotal role of IFN regulatory factor 3.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: May 21, 2010
Primer: signal transduction in rheumatic disease--a clinician's guide.
Journal: Nature clinical practice. Rheumatology
Published: March 02, 2007
Showing 1-7 of 7
Last Updated: 09/26/2026